{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:57:59Z","timestamp":1781650679903,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To analyse characteristics and SpA features of newly diagnosed patients with radiographic (r-) versus non-radiographic (nr-)axSpA, and nr-axSpA patients fulfilling the imaging versus clinical arm of the ASAS classification criteria. Furthermore, this study explored whether patients from the clinical arm developed imaging evidence of sacroiliitis during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Consecutive newly diagnosed axSpA patients included in the prospective GLAS cohort between 2009 and 2019 were analysed. Demographic data and SpA features were compared between groups using multivariable logistic regression analysis. Patients fulfilling the clinical arm were evaluated for the development of radiographic sacroiliitis during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      305 patients with a recent axSpA diagnosis were included. Mean age was 38\u2009\u00b1\u200912 years, 55% were males, median diagnostic delay was 6 (IQR 2\u201313) years, and 75% were HLA-B27+. Patients diagnosed with r-axSpA (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009170; 56%) were more often male and had more often elevated CRP than patients diagnosed with nr-axSpA. Patients with nr-axSpA had more often inflammatory back pain and a positive family history of SpA. Clinical diagnosis was made without imaging evidence of sacroiliitis in 38 (12%) patients. Only 2 (5%) of these patients later developed sacroiliitis on imaging (median follow-up 8 years).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overall, diagnosed and classified axSpA patients have similar clinical presentation and disease burden. In approximately 1 in 10 patients, axSpA diagnosis was made without imaging evidence of sacroiliitis, with a negligible number developing sacroiliitis on imaging during long-term follow-up. Imaging may improve diagnostic confidence, which can prevent reconsideration of the diagnosis and reduce inappropriate management decisions and expectations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-026-03811-z","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:56:46Z","timestamp":1776859006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insights into axial spondyloarthritis features and the development of imaging evidence of sacroiliitis during long-term follow-up in routine clinical practice"],"prefix":"10.1186","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5511-3761","authenticated-orcid":false,"given":"Stan Corn\u00e9","family":"Kieskamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan Jolanda","family":"Nijmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9ke","family":"Wink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Arends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"Spoorenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"12","key":"3811_CR1","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/annrheumdis-2021-221035","volume":"80","author":"V Navarro-Comp\u00e1n","year":"2021","unstructured":"Navarro-Comp\u00e1n V, Sepriano A, El-Zorkany B, et al. Axial spondyloarthritis. Ann Rheum Dis. 2021;80(12):1511\u201321.","journal-title":"Ann Rheum Dis"},{"key":"3811_CR2","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1007\/s10067-021-05679-7","volume":"40","author":"MC Hwang","year":"2021","unstructured":"Hwang MC, Ridley L, Reveille JD. Ankylosing spondylitis risk factors: a systematic literature review. Clin Rheumatol. 2021;40:3079\u201393.","journal-title":"Clin Rheumatol"},{"key":"3811_CR3","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1093\/rheumatology\/keab901","volume":"61","author":"D Poddubnyy","year":"2022","unstructured":"Poddubnyy D, Sieper J, Akar S, et al. Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results. Rheumatology (Oxford). 2022;61:3299\u2013308.","journal-title":"Rheumatology (Oxford)"},{"key":"3811_CR4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777\u201383.","journal-title":"Ann Rheum Dis"},{"key":"3811_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10067-020-05269-z","volume":"40","author":"T Ot\u00f3n","year":"2021","unstructured":"Ot\u00f3n T, Sastre C, Carmona L. The journey of the non-radiographic axial spondyloarthritis patient: the perspective of professionals and patients. Clin Rheumatol. 2021;40:591\u2013600.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"3811_CR6","doi-asserted-by":"publisher","first-page":"e000825","DOI":"10.1136\/rmdopen-2018-000825","volume":"4","author":"D Poddubnyy","year":"2018","unstructured":"Poddubnyy D, Callhoff J, Spiller I, et al. Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care. RMD Open. 2018;4(2):e000825.","journal-title":"RMD Open"},{"key":"3811_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/1759720X18773726","volume":"10","author":"F Proft","year":"2018","unstructured":"Proft F, Poddubnyy D. Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria. Ther Adv Musculoskelet Dis. 2018;10:129\u201339.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"3811_CR8","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.semarthrit.2016.11.003","volume":"46","author":"F Maas","year":"2017","unstructured":"Maas F, Spoorenberg A, Brouwer E, et al. Radiographic damage and progression of the cervical spine in ankylosing spondylitis patients treated with TNF- \u03b1 inhibitors: Facet joints vs. vertebral bodies. Semin Arthritis Rheum. 2017;46:562\u20138.","journal-title":"Semin Arthritis Rheum"},{"key":"3811_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum. 1984;27:361\u20138.","journal-title":"Arthritis Rheum"},{"key":"3811_CR10","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68:ii1\u201344.","journal-title":"Ann Rheum Dis"},{"key":"3811_CR11","doi-asserted-by":"publisher","first-page":"e001108","DOI":"10.1136\/rmdopen-2019-001108","volume":"5","author":"C L\u00f3pez-Medina","year":"2019","unstructured":"L\u00f3pez-Medina C, Ramiro S, van der Heijde D, et al. Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD open. 2019;5:e001108.","journal-title":"RMD open"},{"key":"3811_CR12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1136\/ard.2006.060293","volume":"66","author":"W Lee","year":"2007","unstructured":"Lee W, Reveille JD, Davis JC, et al. Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis. 2007;66:633\u20138.","journal-title":"Ann Rheum Dis"},{"key":"3811_CR13","doi-asserted-by":"publisher","first-page":"e0177231","DOI":"10.1371\/journal.pone.0177231","volume":"12","author":"F Maas","year":"2017","unstructured":"Maas F, Arends S, Wink FR, et al. Ankylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-\u03b1 inhibitors. PLoS ONE. 2017;12:e0177231.","journal-title":"PLoS ONE"},{"key":"3811_CR14","first-page":"184","volume":"6","author":"S Akar","year":"2018","unstructured":"Akar S, Kaplan YC, Ecemi\u015f S, et al. The role of smoking in the development and progression of structural damage in axial SpA patients: A systematic review and meta-analysis. Eur J Rheumatol. 2018;6:184\u201392.","journal-title":"Eur J Rheumatol"},{"key":"3811_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/BOR.0000000000000071","volume":"26","author":"D Poddubnyy","year":"2014","unstructured":"Poddubnyy D, Sieper J. Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment. Curr Opin Rheumatol. 2014;26:377\u201383.","journal-title":"Curr Opin Rheumatol"},{"key":"3811_CR16","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/ard.2010.145995","volume":"70","author":"D Poddubnyy","year":"2011","unstructured":"Poddubnyy D, Rudwaleit M, Haibel H, et al. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis. 2011;70:1369\u201374.","journal-title":"Ann Rheum Dis"},{"key":"3811_CR17","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1097\/RHU.0000000000001575","volume":"27","author":"JA Walsh","year":"2021","unstructured":"Walsh JA, Magrey M. Clinical Manifestations and Diagnosis of Axial Spondyloarthritis. J Clin Rheumatol. 2021;27:e547\u201360.","journal-title":"J Clin Rheumatol"},{"key":"3811_CR18","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1093\/rheumatology\/keae065","volume":"63","author":"AB Da Silva","year":"2024","unstructured":"Da Silva AB, Louren\u00e7o MH, Ramiro S, et al. Performance of clinical, laboratory and imaging features for diagnosing spondyloarthritis-a systematic literature review and meta-analysis. Rheumatology (Oxford). 2024;63:2923\u201337.","journal-title":"Rheumatology (Oxford)"},{"key":"3811_CR19","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1093\/rheumatology\/kez095","volume":"58","author":"M van Lunteren","year":"2019","unstructured":"van Lunteren M, van der Heijde D, Sepriano A, et al. Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known? Rheumatology (Oxford). 2019;58:1649\u201354.","journal-title":"Rheumatology (Oxford)"},{"key":"3811_CR20","doi-asserted-by":"publisher","first-page":"608134","DOI":"10.3389\/fimmu.2020.608134","volume":"11","author":"D Wakefield","year":"2020","unstructured":"Wakefield D, Clarke D, McCluskey P. Recent Developments in HLA B27 Anterior Uveitis. Front Immunol. 2020;11:608134.","journal-title":"Front Immunol"},{"key":"3811_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1136\/ard-2022-223595","volume":"82","author":"D van der Heijde","year":"2023","unstructured":"van der Heijde D, Deodhar A, Baraliakos X, et al. Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Ann Rheum Dis. 2023;82:515\u201326.","journal-title":"Ann Rheum Dis"},{"key":"3811_CR22","doi-asserted-by":"publisher","first-page":"e000917","DOI":"10.1136\/rmdopen-2019-000917","volume":"5","author":"J Sieper","year":"2019","unstructured":"Sieper J, Landew\u00e9 R, Magrey M, et al. Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 study. RMD open. 2019;5:e000917.","journal-title":"RMD open"},{"key":"3811_CR23","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13075-016-1093-z","volume":"18","author":"JJ de Winter","year":"2016","unstructured":"de Winter JJ, van Mens LJ, van der Heijde D, et al. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther. 2016;18:196.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"3811_CR24","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/art.40475","volume":"70","author":"J De Winter","year":"2018","unstructured":"De Winter J, De Hooge M, Van de Sande M, et al. Magnetic Resonance Imaging of the Sacroiliac Joints Indicating Sacroiliitis According to the Assessment of SpondyloArthritis international Society Definition in Healthy Individuals, Runners, and Women With Postpartum Back Pain. Arthritis Rheumatol. 2018;70(7):1042\u20138.","journal-title":"Arthritis Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03811-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03811-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03811-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:33:59Z","timestamp":1781649239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03811-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3811"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03811-z","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The GLAS cohort was approved by the local ethics committees of the MCL and the UMCG (RTPO 364\/604). All participants provided written informed consent according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"F.W. was a consultant for Novartis and Abbvie. S.A. was a consultant for Argenx, Novartis, BMS and Galapagos. A.S. has received grant\/research support from Novartis, and acted as a consultant for Abbvie, Pfizer, UCB and Galapagos. The other authors have declared no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}